Atypical Protein Kinase C (aPKC, PKC iota/lambda) levels can be increased in SMO inhibitor-resistant BCC cells and can phosphorylate GLI1 near its zinc-finger DNA binding domain to increase its transcriptional activity [70]. Here, SMO is linked to skin basal cell carcinoma.